Artal Group »

Dynatrace shares owned by Artal Group

Quarter-by-quarter ownership of Dynatrace (DT) shares owned by Artal Group from 13F filings

Historical chart of Artal Group investment in Dynatrace

Tip: Access up to 7 years of quarterly data

All positions including Dynatrace held by Artal Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dynatrace by Artal Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.7M 36k 46.44

More positions owned by Artal Group

Cava Group Ord (CAVA)
Lexicon Pharmaceuticals Com New (LXRX)
Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
Arrowhead Pharmaceuticals Call Option (ARWR)
Morphic Hldg (MORF)
Apellis Pharmaceuticals (APLS)
Springworks Therapeutics (SWTX)
Crinetics Pharmaceuticals In (CRNX)
Beigene Sponsored Adr (BGNE)
Silence Therapeutics Ads (SLN)
Dyne Therapeutics (DYN)
Revolution Medicines (RVMD)
Kura Oncology (KURA)
Neumora Therapeutics (NMRA)

View all positions for Artal Group

Top funds holding Dynatrace

Vanguard Group
BlackRock
T. Rowe Price Associates
FMR
Brown Advisory Holdings Incorporated
Thoma Bravo
Wellington Management Company
Henderson Group
American Century Companies
Ameriprise Financial
William Blair Investment Management
Geode Capital Management
Amundi
Pictet Asset Management Holding SA
Bank of New York Mellon

View all funds holding Dynatrace